Filana Therapeutics, Inc. (FLNA)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NMS) 
$
0. 70
-0.06
-7.8947%
$
- Market Cap
- P/E Ratio
- Div Yield
327,900 Volume
-2.14 Eps
$ 0.76
Previous Close Investors:
Want to track FLNA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Filana Therapeutics, Inc. (FLNA) Statistics
Valuation metrics
Market Cap -
Enterprise value -48.7M
Trailing P/E (ttm) -0.81
Forward P/E -
PEG ratio -0.01
Price/Sales (ttm) -
Price/Book (mrq) 0.53
Enterprise Value/Revenue -
Enterprise Value/EBITDA 1.16
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 411.43K
Average volume (90 days) 2.03M
Price summary
52-Week low 0.67
52-Week high 4.98
Beta -
50-Day moving average 0.82
200-Day moving average 1.15
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 24 Dec 2012
Ex-Dividend Date 13 Dec 2012
Last split factor 1:7
Last split Date 10 May 2017
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.41%
Return on equity -0.59%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.88
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.71
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 2.08%
Book value per share (mrq) 1.32
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
